Neoadjuvant Chemotherapy With Cisplatin Up‐Regulates GSDMD to Enhance Oral Squamous Cell Carcinoma Metastasis Through MMP14‐Mediated EMT Activation

Documenti analoghi

• Extracellular vesicle surface display of αPD‐L1 and αCD3 antibodies via engineered late domain‐based scaffold to activate T‐cell anti‐tumor immunity
  di: Rui Chen, et al.
  Pubblicazione: (2024)
• Programmable DNA Hydrogels with Zinc Oxide Nanoparticles and Cisplatin for Diagnosis and Treatment of Oral Squamous Cell Carcinoma
  di: Dan Zhao, et al.
  Pubblicazione: (2024)
• CEBPG‐Mediated Palmitic Acid Adaptation of Cancer‐Associated Fibroblasts Drives Metastasis of Oral Squamous Cell Carcinoma
  di: Yiling Duan, et al.
  Pubblicazione: (2026)
• Impacts of Mitochondrial Status After Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma Patients
  di: Kotaro Sugawara, et al.
  Pubblicazione: (2025)
• STEAP1 Suppresses Oral Squamous Cell Carcinoma by Targeting Wnt/β‐Catenin Signalling and EMT
  di: Kuangyu Jin, et al.
  Pubblicazione: (2026)